Portfolio Holdings Detail for ISIN IE00BP3QZD73
Stock Name / FundiShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerIWFS(GBX) LSE
ETF TickerIS3T(EUR) F
ETF TickerIWSZ.LS(USD) CXE
ETF TickerIWSZ.MI(EUR) CXE
ETF TickerIWSZ(EUR) ETF Plus
ETF TickerIWFS.L(GBP) LSE

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $288.7 million dollar outflow -- that's a 5.9% decrease week over week - 2025-05-09 14:52:51
Alnylam Pharmaceuticals (NASDAQ:ALNY) Trading 4% Higher Following Analyst Upgrade
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report)’s stock price was up 4% during mid-day trading on Monday after UBS Group raised their price target on the stock from $331.00 to $349.00. UBS Group currently has a buy rating on the stock. Alnylam Pharmaceuticals traded as high as $271.09 and last traded at $269.86. Approximately […] - 2025-05-07 05:24:42
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $349.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by UBS Group from $331.00 to $349.00 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on ALNY. Scotiabank upped their price objective on […] - 2025-05-05 07:25:01
Alnylam Pharmaceuticals (NASDAQ:ALNY) Cut to “Hold” at StockNews.com
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. Other equities analysts have also recently issued research reports about the stock. Sanford C. Bernstein decreased their price objective on shares of Alnylam Pharmaceuticals from $314.00 to […] - 2025-05-02 05:16:49
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
My definition of a high yield is any yield at least twice the level of the S&P 500's yield. The threshold is currently around 2.56%. An ultra-high yield, in my view, is one that's four times higher than the S&P 500's yield. To reach that lofty level, a yield would need to - 2025-04-30 08:51:00
StockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to “Buy”
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday. A number of other equities analysts have also weighed in on the stock. Citigroup boosted their price target on shares of Alnylam Pharmaceuticals […] - 2025-04-24 05:16:58
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $315.58 Consensus PT from Brokerages
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-six analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have given a hold rating and twenty-one have assigned a buy rating to the […] - 2025-04-18 05:44:49
Needham & Company LLC Reaffirms “Buy” Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $320.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s price target would indicate a potential upside of […] - 2025-04-11 06:12:48
Corebridge Financial Inc. Has $520,000 Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Corebridge Financial Inc. lessened its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.2% during the 4th quarter, HoldingsChannel reports. The fund owned 2,209 shares of the biopharmaceutical company’s stock after selling 50 shares during the quarter. Corebridge Financial Inc.’s holdings in Alnylam Pharmaceuticals were worth $520,000 at the end of […] - 2025-04-09 07:44:49
Top Analyst Reports for Broadcom, UnitedHealth & Toyota Motor
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), UnitedHealth Group Incorporated (UNH) and Toyota Motor Corporation (TM), as well as a micro-cap stock Perma-Pipe International Holdings, Inc. (PPIH). - 2025-04-04 20:54:00
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $345.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its target price increased by Stifel Nicolaus from $300.00 to $345.00 in a report released on Monday,Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ price objective suggests a potential upside of 34.89% from the company’s previous close. A number […] - 2025-04-02 05:27:03
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $342.00 Price Target at Scotiabank
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its target price upped by research analysts at Scotiabank from $338.00 to $342.00 in a report issued on Monday,Benzinga reports. The firm presently has a “sector outperform” rating on the biopharmaceutical company’s stock. Scotiabank’s target price would indicate a potential upside of 33.72% from the company’s previous […] - 2025-04-02 05:26:50
Incyte Stock: Is INCY Outperforming the Health Care Sector?
Incyte has outperformed the health care sector over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-04-01 15:55:45
Stocks Recover Early Losses and Close Higher as Magnificent Seven Stocks Rebound
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. June E-mini S&P futures (ESM25 ) are up +0.08%, and June E-mini Nasdaq futures... - 2025-03-24 12:01:12
Natixis Advisors LLC Boosts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Natixis Advisors LLC grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 4.5% during the 4th quarter, HoldingsChannel reports. The fund owned 10,453 shares of the biopharmaceutical company’s stock after acquiring an additional 451 shares during the quarter. Natixis Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $2,460,000 at the […] - 2025-03-24 08:44:53
Needham & Company LLC Reaffirms “Buy” Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Needham & Company LLC reiterated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note released on Friday,Benzinga reports. The brokerage currently has a $320.00 price target on the biopharmaceutical company’s stock. A number of other research firms have also recently issued reports on ALNY. William Blair reissued an […] - 2025-03-24 07:00:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Citigroup Analyst Says
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective upped by Citigroup from $338.00 to $351.00 in a research note released on Friday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other research reports. William Blair reiterated an “outperform” rating on shares […] - 2025-03-24 06:24:53
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $390.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target increased by Canaccord Genuity Group from $385.00 to $390.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on the company. Bank of America raised their […] - 2025-03-24 05:48:46
Royal Bank of Canada Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $330.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Royal Bank of Canada from $310.00 to $330.00 in a research report released on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. StockNews.com downgraded shares of Alnylam Pharmaceuticals […] - 2025-03-24 05:48:44
Stocks Pare Losses as S&P 500 Looks for Weekly Win
The S&P 500 Index ($SPX ) (SPY ) today is down -0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM25 ) are down -0.28%, and June E-mini Nasdaq futures... - 2025-03-21 23:21:08
Weak Corporate Earnings Results Weigh on Stocks
The S&P 500 Index ($SPX ) (SPY ) today is down -0.81%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.97%. March E-mini S&P futures (ESH25 ) are down -0.84%, and March E-mini Nasdaq futures... - 2025-03-21 20:55:40
Stocks Fall on Disappointing Corporate Earnings and Economic Worries
The S&P 500 Index ($SPX ) (SPY ) today is down -0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.53%. June E-mini S&P futures (ESM25 ) are down -0.50%, and June E-mini Nasdaq futures... - 2025-03-21 18:18:20
Friday's ETF Movers: XBI, COPX
In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Alnylam Pharmaceuticals, up about 13.1% and shares of Cytokinetics, up about 7.8% on the day. And unde - 2025-03-21 16:11:45
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by Atria Investments Inc
Atria Investments Inc increased its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,311 shares of the biopharmaceutical company’s stock after acquiring an additional 166 shares during the quarter. Atria Investments Inc’s […] - 2025-03-14 09:52:58
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by Proficio Capital Partners LLC
Proficio Capital Partners LLC lifted its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 25,929.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 193,660 shares of the biopharmaceutical company’s stock after acquiring an additional 192,916 shares during the period. Alnylam Pharmaceuticals makes up approximately 0.6% of Proficio Capital Partners […] - 2025-03-14 09:05:23
USMV's Underlying Holdings Could Mean 11% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-10 11:43:47
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Position Lessened by Principal Financial Group Inc.
Principal Financial Group Inc. lowered its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,378 shares of the biopharmaceutical company’s stock after selling 230 shares during the quarter. Principal Financial Group Inc.’s holdings […] - 2025-03-06 10:01:07
New York Life Investment Management LLC Boosts Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
New York Life Investment Management LLC increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,384 shares of the biopharmaceutical company’s stock after buying an additional 153 shares during the period. […] - 2025-03-05 10:04:47
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $299.48
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-five research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nineteen have issued a buy […] - 2025-02-27 06:53:09
Sanctuary Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sanctuary Advisors LLC boosted its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,915 shares of the biopharmaceutical company’s stock after purchasing an additional 357 shares during the period. Sanctuary […] - 2025-02-26 08:50:51

iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2025-05-08 (Thursday)1,374USD 354,973ALNY holding decreased by -25007USD 354,9730USD -25,007 USD 258.35 USD 276.55
2025-05-07 (Wednesday)1,374USD 379,980ALNY holding increased by 9261USD 379,9800USD 9,261 USD 276.55 USD 269.81
2025-05-06 (Tuesday)1,374USD 370,719ALNY holding decreased by -5139USD 370,7190USD -5,139 USD 269.81 USD 273.55
2025-05-05 (Monday)1,374USD 375,858ALNY holding increased by 19456USD 375,8580USD 19,456 USD 273.55 USD 259.39
2025-05-02 (Friday)1,374USD 356,402ALNY holding increased by 5853USD 356,4020USD 5,853 USD 259.39 USD 255.13
2025-05-01 (Thursday)1,374USD 350,549ALNY holding decreased by -11143USD 350,5490USD -11,143 USD 255.13 USD 263.24
2025-04-30 (Wednesday)1,374USD 361,692ALNY holding increased by 8313USD 361,6920USD 8,313 USD 263.24 USD 257.19
2025-04-29 (Tuesday)1,374USD 353,379ALNY holding increased by 3215USD 353,3790USD 3,215 USD 257.19 USD 254.85
2025-04-28 (Monday)1,374USD 350,164ALNY holding increased by 4521USD 350,1640USD 4,521 USD 254.85 USD 251.56
2025-04-25 (Friday)1,374USD 345,643ALNY holding increased by 12297USD 345,6430USD 12,297 USD 251.56 USD 242.61
2025-04-24 (Thursday)1,374USD 333,346ALNY holding increased by 879USD 333,3460USD 879 USD 242.61 USD 241.97
2025-04-23 (Wednesday)1,374USD 332,467ALNY holding increased by 7172USD 332,4670USD 7,172 USD 241.97 USD 236.75
2025-04-22 (Tuesday)1,374USD 325,295ALNY holding increased by 5496USD 325,2950USD 5,496 USD 236.75 USD 232.75
2025-04-21 (Monday)1,374USD 319,799ALNY holding decreased by -2486USD 319,7990USD -2,486 USD 232.75 USD 234.56
2025-04-18 (Friday)1,374USD 322,285USD 322,2850USD 0 USD 234.56 USD 234.56
2025-04-17 (Thursday)1,374USD 322,285ALNY holding increased by 5578USD 322,2850USD 5,578 USD 234.56 USD 230.5
2025-04-16 (Wednesday)1,374USD 316,707ALNY holding decreased by -591USD 316,7070USD -591 USD 230.5 USD 230.93
2025-04-15 (Tuesday)1,374USD 317,298ALNY holding decreased by -12476USD 317,2980USD -12,476 USD 230.93 USD 240.01
2025-04-14 (Monday)1,374USD 329,774ALNY holding increased by 3078USD 329,7740USD 3,078 USD 240.01 USD 237.77
2025-04-11 (Friday)1,374USD 326,696ALNY holding increased by 15787USD 326,6960USD 15,787 USD 237.77 USD 226.28
2025-04-10 (Thursday)1,374USD 310,909ALNY holding decreased by -23344USD 310,9090USD -23,344 USD 226.28 USD 243.27
2025-04-09 (Wednesday)1,374USD 334,253ALNY holding increased by 26037USD 334,2530USD 26,037 USD 243.27 USD 224.32
2025-04-08 (Tuesday)1,374USD 308,216ALNY holding decreased by -11857USD 308,2160USD -11,857 USD 224.32 USD 232.95
2025-04-07 (Monday)1,374USD 320,073ALNY holding decreased by -3834USD 320,0730USD -3,834 USD 232.95 USD 235.74
2025-04-04 (Friday)1,374USD 323,907ALNY holding decreased by -42717USD 323,9070USD -42,717 USD 235.74 USD 266.83
2025-04-02 (Wednesday)1,374USD 366,624ALNY holding increased by 15210USD 366,6240USD 15,210 USD 266.83 USD 255.76
2025-04-01 (Tuesday)1,374ALNY holding increased by 52USD 351,414ALNY holding decreased by -5552USD 351,41452USD -5,552 USD 255.76 USD 270.02
2025-03-31 (Monday)1,322USD 356,966ALNY holding increased by 2062USD 356,9660USD 2,062 USD 270.02 USD 268.46
2025-03-28 (Friday)1,322USD 354,904ALNY holding decreased by -3384USD 354,9040USD -3,384 USD 268.46 USD 271.02
2025-03-27 (Thursday)1,322USD 358,288ALNY holding increased by 2392USD 358,2880USD 2,392 USD 271.02 USD 269.21
2025-03-26 (Wednesday)1,322USD 355,896ALNY holding decreased by -15533USD 355,8960USD -15,533 USD 269.21 USD 280.96
2025-03-25 (Tuesday)1,322USD 371,429ALNY holding decreased by -12876USD 371,4290USD -12,876 USD 280.96 USD 290.7
2025-03-24 (Monday)1,322USD 384,305ALNY holding increased by 9730USD 384,3050USD 9,730 USD 290.7 USD 283.34
2025-03-21 (Friday)1,322USD 374,575ALNY holding increased by 39395USD 374,5750USD 39,395 USD 283.34 USD 253.54
2025-03-20 (Thursday)1,322USD 335,180ALNY holding increased by 132USD 335,1800USD 132 USD 253.54 USD 253.44
2025-03-19 (Wednesday)1,322USD 335,048ALNY holding increased by 12083USD 335,0480USD 12,083 USD 253.44 USD 244.3
2025-03-18 (Tuesday)1,322USD 322,965ALNY holding decreased by -11646USD 322,9650USD -11,646 USD 244.3 USD 253.11
2025-03-17 (Monday)1,322USD 334,611ALNY holding increased by 15004USD 334,6110USD 15,004 USD 253.11 USD 241.76
2025-03-14 (Friday)1,322USD 319,607ALNY holding increased by 13USD 319,6070USD 13 USD 241.76 USD 241.75
2025-03-13 (Thursday)1,322USD 319,594ALNY holding decreased by -898USD 319,5940USD -898 USD 241.75 USD 242.43
2025-03-12 (Wednesday)1,322USD 320,492ALNY holding increased by 4878USD 320,4920USD 4,878 USD 242.43 USD 238.74
2025-03-11 (Tuesday)1,322USD 315,614ALNY holding increased by 7495USD 315,6140USD 7,495 USD 238.74 USD 233.07
2025-03-10 (Monday)1,322USD 308,119ALNY holding decreased by -15136USD 308,1190USD -15,136 USD 233.07 USD 244.52
2025-03-07 (Friday)1,322USD 323,255ALNY holding decreased by -6227USD 323,2550USD -6,227 USD 244.52 USD 249.23
2025-03-05 (Wednesday)1,322USD 329,482ALNY holding increased by 8329USD 329,4820USD 8,329 USD 249.23 USD 242.93
2025-03-04 (Tuesday)1,322USD 321,153ALNY holding decreased by -794USD 321,1530USD -794 USD 242.93 USD 243.53
2025-03-03 (Monday)1,322USD 321,947ALNY holding decreased by -4257USD 321,9470USD -4,257 USD 243.53 USD 246.75
2025-02-28 (Friday)1,322USD 326,204ALNY holding increased by 12758USD 326,2040USD 12,758 USD 246.75 USD 237.1
2025-02-27 (Thursday)1,322USD 313,446ALNY holding decreased by -8937USD 313,4460USD -8,937 USD 237.1 USD 243.86
2025-02-26 (Wednesday)1,322USD 322,383ALNY holding decreased by -1771USD 322,3830USD -1,771 USD 243.86 USD 245.2
2025-02-25 (Tuesday)1,322USD 324,154ALNY holding decreased by -4945USD 324,1540USD -4,945 USD 245.2 USD 248.94
2025-02-24 (Monday)1,322ALNY holding increased by 67USD 329,099ALNY holding increased by 14609USD 329,09967USD 14,609 USD 248.94 USD 250.59
2025-02-21 (Friday)1,255USD 314,490ALNY holding decreased by -515USD 314,4900USD -515 USD 250.59 USD 251
2025-02-20 (Thursday)1,255USD 315,005ALNY holding increased by 615USD 315,0050USD 615 USD 251 USD 250.51
2025-02-19 (Wednesday)1,255USD 314,390ALNY holding increased by 640USD 314,3900USD 640 USD 250.51 USD 250
2025-02-18 (Tuesday)1,255USD 313,750ALNY holding decreased by -8095USD 313,7500USD -8,095 USD 250 USD 256.45
2025-02-17 (Monday)1,255USD 321,845USD 321,8450USD 0 USD 256.45 USD 256.45
2025-02-14 (Friday)1,255USD 321,845ALNY holding decreased by -10592USD 321,8450USD -10,592 USD 256.45 USD 264.89
2025-02-13 (Thursday)1,255USD 332,437ALNY holding decreased by -1343USD 332,4370USD -1,343 USD 264.89 USD 265.96
2025-02-12 (Wednesday)1,255USD 333,780ALNY holding decreased by -3802USD 333,7800USD -3,802 USD 265.96 USD 268.99
2025-02-11 (Tuesday)1,255USD 337,582ALNY holding decreased by -6363USD 337,5820USD -6,363 USD 268.99 USD 274.06
2025-02-10 (Monday)1,255USD 343,945ALNY holding decreased by -2673USD 343,9450USD -2,673 USD 274.06 USD 276.19
2025-02-07 (Friday)1,255USD 346,618ALNY holding decreased by -2586USD 346,6180USD -2,586 USD 276.19 USD 278.25
2025-02-06 (Thursday)1,255USD 349,204ALNY holding increased by 2435USD 349,2040USD 2,435 USD 278.25 USD 276.31
2025-02-05 (Wednesday)1,255USD 346,769ALNY holding increased by 6664USD 346,7690USD 6,664 USD 276.31 USD 271
2025-02-04 (Tuesday)1,255USD 340,105ALNY holding decreased by -4455USD 340,1050USD -4,455 USD 271 USD 274.55
2025-02-03 (Monday)1,255ALNY holding decreased by -67USD 344,560ALNY holding decreased by -14112USD 344,560-67USD -14,112 USD 274.55 USD 271.31
2025-01-31 (Friday)1,322USD 358,672ALNY holding decreased by -7734USD 358,6720USD -7,734 USD 271.31 USD 277.16
2025-01-30 (Thursday)1,322USD 366,406ALNY holding increased by 4191USD 366,4060USD 4,191 USD 277.16 USD 273.99
2025-01-29 (Wednesday)1,322USD 362,215ALNY holding decreased by -6874USD 362,2150USD -6,874 USD 273.99 USD 279.19
2025-01-28 (Tuesday)1,322USD 369,089ALNY holding increased by 3252USD 369,0890USD 3,252 USD 279.19 USD 276.73
2025-01-27 (Monday)1,322USD 365,837ALNY holding decreased by -2684USD 365,8370USD -2,684 USD 276.73 USD 278.76
2025-01-24 (Friday)1,322USD 368,521ALNY holding increased by 4257USD 368,5210USD 4,257 USD 278.76 USD 275.54
2025-01-23 (Thursday)1,322USD 364,264ALNY holding increased by 11898USD 364,2640USD 11,898 USD 275.54 USD 266.54
2025-01-22 (Wednesday)1,322USD 352,366USD 352,366
2025-01-21 (Tuesday)1,322USD 350,317USD 350,317
2025-01-20 (Monday)1,322USD 325,569USD 325,569
2025-01-17 (Friday)1,322USD 325,569USD 325,569
2025-01-16 (Thursday)1,322USD 329,390USD 329,390
2025-01-15 (Wednesday)1,322USD 331,835USD 331,835
2025-01-14 (Tuesday)1,322USD 317,954USD 317,954
2025-01-13 (Monday)1,322USD 341,433USD 341,433
2025-01-10 (Friday)1,322USD 314,610USD 314,610
2025-01-09 (Thursday)1,322USD 318,007USD 318,007
2025-01-09 (Thursday)1,322USD 318,007USD 318,007
2025-01-09 (Thursday)1,322USD 318,007USD 318,007
2025-01-08 (Wednesday)1,322USD 318,007USD 318,007
2025-01-08 (Wednesday)1,322USD 318,007USD 318,007
2025-01-08 (Wednesday)1,322USD 318,007USD 318,007
2025-01-02 (Thursday)1,389USD 324,498ALNY holding decreased by -28183USD 324,4980USD -28,183 USD 233.62 USD 253.91
2024-12-30 (Monday)1,389USD 327,818USD 327,818
2024-12-10 (Tuesday)1,389USD 352,681ALNY holding decreased by -2750USD 352,6810USD -2,750 USD 253.91 USD 255.89
2024-12-09 (Monday)1,389USD 355,431ALNY holding decreased by -514USD 355,4310USD -514 USD 255.89 USD 256.26
2024-12-06 (Friday)1,389USD 355,945ALNY holding increased by 6181USD 355,9450USD 6,181 USD 256.26 USD 251.81
2024-12-05 (Thursday)1,389USD 349,764ALNY holding decreased by -4042USD 349,7640USD -4,042 USD 251.81 USD 254.72
2024-12-04 (Wednesday)1,389USD 353,806ALNY holding increased by 4000USD 353,8060USD 4,000 USD 254.72 USD 251.84
2024-12-03 (Tuesday)1,389USD 349,806ALNY holding decreased by -1625USD 349,8060USD -1,625 USD 251.84 USD 253.01
2024-12-02 (Monday)1,389USD 351,431ALNY holding decreased by -83USD 351,4310USD -83 USD 253.01 USD 253.07
2024-11-29 (Friday)1,389USD 351,514ALNY holding decreased by -931USD 351,5140USD -931 USD 253.07 USD 253.74
2024-11-28 (Thursday)1,389USD 352,445USD 352,4450USD 0 USD 253.74 USD 253.74
2024-11-27 (Wednesday)1,389USD 352,445ALNY holding increased by 542USD 352,4450USD 542 USD 253.74 USD 253.35
2024-11-26 (Tuesday)1,389USD 351,903ALNY holding increased by 3292USD 351,9030USD 3,292 USD 253.35 USD 250.98
2024-11-25 (Monday)1,389ALNY holding decreased by -918USD 348,611ALNY holding decreased by -216350USD 348,611-918USD -216,350 USD 250.98 USD 244.89
2024-11-22 (Friday)2,307USD 564,961ALNY holding decreased by -4407USD 564,9610USD -4,407 USD 244.89 USD 246.8
2024-11-21 (Thursday)2,307USD 569,368ALNY holding decreased by -4591USD 569,3680USD -4,591 USD 246.8 USD 248.79
2024-11-20 (Wednesday)2,307USD 573,959ALNY holding increased by 33498USD 573,9590USD 33,498 USD 248.79 USD 234.27
2024-11-19 (Tuesday)2,307USD 540,461ALNY holding increased by 4614USD 540,4610USD 4,614 USD 234.27 USD 232.27
2024-11-18 (Monday)2,307ALNY holding increased by 110USD 535,847ALNY holding decreased by -55036USD 535,847110USD -55,036 USD 232.27 USD 268.95
2024-11-12 (Tuesday)2,197USD 590,883ALNY holding decreased by -18631USD 590,8830USD -18,631 USD 268.95 USD 277.43
2024-11-08 (Friday)2,197USD 609,514ALNY holding increased by 11447USD 609,5140USD 11,447 USD 277.43 USD 272.22
2024-11-07 (Thursday)2,197USD 598,067ALNY holding decreased by -1736USD 598,0670USD -1,736 USD 272.22 USD 273.01
2024-11-06 (Wednesday)2,197USD 599,803ALNY holding increased by 16961USD 599,8030USD 16,961 USD 273.01 USD 265.29
2024-11-05 (Tuesday)2,197USD 582,842ALNY holding decreased by -10238USD 582,8420USD -10,238 USD 265.29 USD 269.95
2024-11-04 (Monday)2,197USD 593,080ALNY holding decreased by -8700USD 593,0800USD -8,700 USD 269.95 USD 273.91
2024-11-01 (Friday)2,197USD 601,780ALNY holding increased by 16082USD 601,7800USD 16,082 USD 273.91 USD 266.59
2024-10-31 (Thursday)2,197USD 585,698ALNY holding decreased by -32736USD 585,6980USD -32,736 USD 266.59 USD 281.49
2024-10-30 (Wednesday)2,197USD 618,434ALNY holding decreased by -7030USD 618,4340USD -7,030 USD 281.49 USD 284.69
2024-10-29 (Tuesday)2,197USD 625,464ALNY holding decreased by -4877USD 625,4640USD -4,877 USD 284.69 USD 286.91
2024-10-28 (Monday)2,197USD 630,341ALNY holding increased by 4504USD 630,3410USD 4,504 USD 286.91 USD 284.86
2024-10-25 (Friday)2,197USD 625,837ALNY holding decreased by -19400USD 625,8370USD -19,400 USD 284.86 USD 293.69
2024-10-24 (Thursday)2,197USD 645,237ALNY holding decreased by -2592USD 645,2370USD -2,592 USD 293.69 USD 294.87
2024-10-23 (Wednesday)2,197USD 647,829ALNY holding decreased by -3538USD 647,8290USD -3,538 USD 294.87 USD 296.48
2024-10-22 (Tuesday)2,197USD 651,367ALNY holding increased by 9821USD 651,3670USD 9,821 USD 296.48 USD 292.01
2024-10-21 (Monday)2,197USD 641,546ALNY holding decreased by -8612USD 641,5460USD -8,612 USD 292.01 USD 295.93
2024-10-18 (Friday)2,197USD 650,158USD 650,158
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE00BP3QZD73

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-01BUY52 255.760* 261.74
2025-02-24BUY67 248.940* 265.41
2025-02-03SELL-67 274.550* 265.80 Profit of 17,809 on sale
2024-11-25SELL-918 250.980* 270.92 Profit of 248,707 on sale
2024-11-18BUY110 232.270* 280.15
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-09170,9551,137323,38652.9%
2025-05-08382,5811,581899,41642.5%
2025-05-07131,4462,828218,31160.2%
2025-05-06517,9117,413716,63772.3%
2025-05-05304,3563,848527,58957.7%
2025-05-02136,0073,773208,06965.4%
2025-05-01363,746490677,63553.7%
2025-04-30237,6844,832415,33857.2%
2025-04-29198,3895,983331,26759.9%
2025-04-28136,8421,137229,40759.7%
2025-04-25222,7761,993348,40763.9%
2025-04-24115,1631,767238,25748.3%
2025-04-23208,801464350,36459.6%
2025-04-22136,015231332,84940.9%
2025-04-21209,611603306,74268.3%
2025-04-17165,45174243,55867.9%
2025-04-16270,2943,357446,37060.6%
2025-04-15238,076403494,21648.2%
2025-04-14157,1483,912316,10849.7%
2025-04-11486,93714,123679,58371.7%
2025-04-10500,5972,591780,52664.1%
2025-04-09557,11511,336965,76057.7%
2025-04-08214,0941,301383,79455.8%
2025-04-07358,67932,038613,76358.4%
2025-04-04431,5561,025725,19559.5%
2025-04-03342,351477430,26279.6%
2025-04-02233,8961,506378,45961.8%
2025-04-01183,2658,200380,24848.2%
2025-03-31210,7774,770352,19159.8%
2025-03-28133,425181279,76547.7%
2025-03-27203,5676,557375,58354.2%
2025-03-26285,1751,249426,22666.9%
2025-03-25281,68810,979412,44068.3%
2025-03-24482,33425,397826,00858.4%
2025-03-21836,06628,3231,366,24861.2%
2025-03-20192,017151422,45045.5%
2025-03-19179,75963447,45240.2%
2025-03-18180,640478331,28254.5%
2025-03-17121,129153260,37646.5%
2025-03-14105,1308,747179,06158.7%
2025-03-1370,794138132,71653.3%
2025-03-12124,07084268,28746.2%
2025-03-11137,7132,010247,32355.7%
2025-03-1077,72466208,12337.3%
2025-03-07116,885207186,95062.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.